Target intelligence / Profile preview

HIV-1 Gag, Pol, Vif, and Nef proteins (None, but commonly referenced as Gag, Pol, Vif, and Nef individually)

Target
None, but commonly referenced as Gag, Pol, Vif, and Nef individually
Molecular classification
Gag: Structural protein (precursor polyprotein with subunits—matrix, capsid, nucleocapsid, p6), Pol: Enzyme polyprotein (encodes protease, reverse transcriptase, integrase), Vif: Accessory protein, Nef: Accessory protein
01

Overview

The HIV-1 Gag, Pol, Vif, and Nef proteins are critical viral gene products encoded by the HIV-1 genome, each fulfilling distinct functions essential to the viral replication cycle and pathogenesis[1][2][3][5].\n- Gag is the major structural polyprotein, involved in viral assembly, budding from the host cell, and formation of virus-like particles; upon cleavage, it yields matrix, capsid, nucleocapsid, and p6 proteins[1][2][6].\n- Pol is a polyprotein precursor encoding the enzymes protease, reverse transcriptase, and integrase, required for maturation, viral DNA synthesis, and genome integration, respectively—making it a major target of current antiretroviral drugs[2][7][8].\n- Vif is an accessory protein that protects the virus from the host restriction factor APOBEC3G and optimizes infectivity by stabilizing the viral nucleoprotein complex and modulating reverse transcriptase[3].\n- Nef is another accessory protein facilitating immune evasion (by downregulating host CD4 and MHC-I), enhancing replication efficiency, and is a key factor in HIV-1 pathogenicity[3][4].\nDespite overlapping involvement in the HIV life cycle, these proteins are biologically, structurally, and functionally distinct and are usually considered individually as targets for therapeutic or diagnostic development.

Other names
Gag (Group-specific antigen)Pol (Polymerase polyprotein)Vif (Virion infectivity factor)Nef (Negative regulatory factor)
02

Mechanism of action

Inhibition of viral protease (prevents maturation, noninfectious particles)\nInhibition of reverse transcriptase (blocks synthesis of viral DNA)\nInhibition of integrase (preve`nts integration of viral genome into host DNA)\nGag inhibitors (maturation inhibitors) disrupt virion assembly\nExperimental approaches for Vif and Nef block immune evasion or viral replication enhancement

03

Biological functions

Gag: Virion assembly, budding, morphogenesisPol: Viral genome replication and integration (enzymatic activity)Vif: Suppression of host innate immunity (e.g., inactivation of APOBEC3G), enhancement of viral infectivityNef: Immune evasion (CD4/MHC-I downregulation), enhancement of viral replication and pathogenicity, modulation of signal transduction
04

Disease associations

Infection (HIV/AIDS pathogenesis)
05

Safety considerations

Drug resistance (mutations in Pol rapidly confer resistance to protease/reverse transcriptase/integrase inhibitors)Viral reservoirs (latency, particularly impacting efficacy of targeting non-Pol proteins)Off-target toxicity of host-directed or broad-acting antiviral therapies
06

Interacting drugs

Pol: Numerous antiretroviral drugs: Protease inhibitors (e.g., lopinavir, darunavir)

4 more in the full profile.

07

Biomarkers

HIV-1 p24 antigen (part of Gag) is a widely used biomarker for early HIV infectionHIV-1 viral RNA, reverse transcriptase activity, or presence of proviral DNA (for monitoring antiretroviral efficacy)

Beyond the preview

Go deeper on HIV-1 Gag, Pol, Vif, and Nef proteins (None, but commonly referenced as Gag, Pol, Vif, and Nef individually).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 Gag, Pol, Vif, and Nef proteins (None, but commonly referenced as Gag, Pol, Vif, and Nef individually).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call